A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice

Jae Hyeog Choi, Ki Hyang Kim, Kug Hwan Roh, Hana Jung, Anbok Lee, Ji Young Lee, Joo Yeon Song, Seung Jae Park, Ilhwan Kim, Won Sik Lee, Su Kil Seo, Il Whan Choi, Yang Xin Fu, Sung Su Yea, Sae Gwang Park

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice'. Together they form a unique fingerprint.

Medicine & Life Sciences